CD34 and neoplasm: In another study, treatment with oral Vit D3 in patients with HNSCC reduced the number of immune suppressive CD34+ cells and skewed immune system toward an anti-tumor Th1 immune response (Lathers et al., 2004; Ugel et al., 2009).